Restoration of mitochondria function as a target for cancer therapy.

Drug Discov Today

Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA. Electronic address:

Published: May 2015

Defective oxidative phosphorylation has a crucial role in the attenuation of mitochondrial function, which confers therapy resistance in cancer. Various factors, including endogenous heat shock proteins (HSPs) and exogenous agents such as dichloroacetate, restore respiratory and other physiological functions of mitochondria in cancer cells. Functional mitochondria might ultimately lead to the restoration of apoptosis in cancer cells that are refractory to current anticancer agents. Here, we summarize the key reasons contributing to mitochondria dysfunction in cancer cells and how restoration of mitochondrial function could be exploited for cancer therapeutics.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433775PMC
http://dx.doi.org/10.1016/j.drudis.2015.03.001DOI Listing

Publication Analysis

Top Keywords

cancer cells
12
mitochondrial function
8
cancer
6
restoration mitochondria
4
mitochondria function
4
function target
4
target cancer
4
cancer therapy
4
therapy defective
4
defective oxidative
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!